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Abstract
Purpose Alcohol consumption can lead to worse prognosis and mortality among colorectal cancer (CRC) patients. We inves-
tigated alcohol consumption of CRC survivors up to 2 years post-diagnosis, and how sociodemographic, lifestyle, and clinical
factors were associated longitudinally with these habits.
Methods We pooled longitudinal data of 910 CRC survivors from the ongoing PROCORE and EnCoRe studies with
data collected at diagnosis (baseline) and 3, 6, 12, and 24 months post-diagnosis. Both studies assessed alcohol
consumption, including beer, wine, and liquor. Generalized estimated equation models were used to examine changes
over time in alcohol consumption and multivariable longitudinal associations of sociodemographic, lifestyle, and
clinical factors with alcohol consumption.
Results At baseline, participants were on average 67 years old, 332 (37%) were female, and alcohol was consumed by 79%.Most
survivors (68–71%) drank less at all follow-ups. Beer, wine, and liquor were consumed by 51%, 58%, and 25% at baseline,
respectively, and these declined over time. Males consumed more alcohol, and higher education, more physical activity, and not
having a (permanent) stoma were associated with consuming more alcohol.
Conclusion CRC survivors decreased their alcohol consumption in the 2 years post-diagnosis. Future studies should take the
significant factors that were associated with alcohol post-diagnosis consumption into account, when they investigate CRC health
outcomes or for identifying subgroups for interventions. Males with higher education, more physical activity, and no stoma
should be reminded after diagnosis for reducing their alcohol consumption.
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Introduction
Colorectal cancer (CRC) is the second most common oc-
curring cancer with ~ 500,000 cases, the cause of 43,000
cancer deaths in Europe each year [1], and the world’s
fourth most deadly cancer type [2]. As a result of rising
survival rates due to improved treatments and implemen-
tation of screening programs, the number of CRC survivors
is increasing [3]. Alcohol consumption is a major risk fac-
tor for CRC [4] due to ethanol-induced DNA damage, epi-
genetics, and diet as potential causal mechanisms [5]. It has
been suggested that alcohol may have a subsite-specific
effect, affecting the rectum more than the colon [6]. A
systematic analysis within the Global Burden of Disease
Study found that the risk of all-cause mortality, and spe-
cifically of cancers, rises with increasing levels of alcohol
consumption, and that for global disease burden and over-
all health, it is best not to consume at all [7]. Also, accord-
ing to the World Cancer Research Fund/American Institute
for Cancer Research (WCRF/AICR) report on lifestyle and
cancer in 2018, all alcohol is detrimental to cancer and its
prognosis [8]. The report makes no differences in cancer
risk between the alcoholic beverage types (i.e., beer, wine,
and liquor) [8]. Furthermore, this report recommends that
cancer survivors (including CRC) should not consume any
alcohol or, if they do, to limit it to national guidelines [8].
However, this recommendation is predominantly based on
studies focusing on the risk of getting a cancer diagnosis,
and includes only limited evidence on survivorship or mor-
tality. Currently, little evidence is available regarding al-
cohol consumption and its determinants after a CRC diag-
nosis and how this is related to prognostic outcomes [9].
Some studies on alcohol consumption have been per-
formed in cancer survivors, yet only a few have been
longitudinal. To our knowledge, only a small number of
studies looked at post-diagnosis alcohol consumption in
CRC survivors, and these studies did not find an associa-
tion with mortality [10–12]. Overall, these studies looked
at alcohol only measured at one time point, instead of
assessing changes over time in alcohol consumption from
diagnosis until years later. Van Zutphen et al. looked at
lifestyle changes in CRC survivors, and whether they
were in concordance with the WCRF/AICR lifestyle rec-
ommendations for cancer prevention during that period:
they reported a slight drop in total alcohol use 6 months
post-diagnosis, then an increase again almost until base-
line values at 2 years post-diagnosis [13]. In order to
know more about the health effects of alcohol consump-
tion in CRC survivors and the effects of alcohol consump-
tion on further pathogenesis of CRC, it is important to
first examine how consumption of alcohol and beverages
is changing over time and which characteristics of CRC
survivors are associated with such changes.
It is important to consider the influences of sociodemographic,
lifestyle, and clinical characteristics on consumption of alcohol
and specific beverage types. Firstly, insight into determinants of
alcohol consumption after CRC may be used in future studies to
facilitate the identification of subgroups at which lifestyle advice
regarding alcohol consumption could be targeted after diagnosis
and treatment. Secondly, these insights can be taken into account
by clinicians who advocate less alcohol consumption to survi-
vors. For instance, Park et al. have looked at the associations
between alcohol use with sociodemographic, lifestyle, and some
disease factors, but have not looked at specific beverage types,
and their analyses were cross-sectional [14]. Also, consumption
was significantly associated with mortality in 603 Chinese rectal
cancer patients after diagnosis, compared to non-drinkers, but not
in colon cancer patients [15]. It also needs to be elucidated in
CRC survivors how alcohol consumption over time is influenced
by treatment factors, such as receiving chemotherapy or radio-
therapy, and having a stoma. Overall, themajority of the research
performed up until now was cross-sectional and has hardly fo-
cused on separate beverage types.
Therefore, we aimed to study longitudinal changes in alco-
hol consumption in CRC survivors from diagnosis until 24
months post-diagnosis, both total alcohol consumption and
consumption of beer, wine, and liquor as separate alcoholic
beverages. We also aimed to analyze how sociodemographic,
lifestyle, and clinical factors are longitudinally associated with
alcohol consumption. Future studies should take these charac-
teristics into account when they investigate the effect of alco-
hol on health outcomes or for identifying subgroups at which
lifestyle advice regarding alcohol consumption could be
targeted after diagnosis and treatment.
Materials and methods
Setting and participants
We used data from EnCoRe and PROCORE: two ongoing
multi-center prospective cohort studies, in which CRC pa-
tients were included immediately after diagnosis, and follow-
ed up at several time points after treatment. We pooled the
datasets and harmonized the time points as shown in Fig. 1.
“Energy for life after ColoRectal cancer” study
Energy for life after ColoRectal cancer (EnCoRe) is an ongo-
ing multi-center prospective cohort study for which adult
stage I–III CRC patients were enrolled at diagnosis and
followed up at 6 weeks, 6 months, and 1 and 2 years after
treatment, which is described in more detail elsewhere [16].
Patients were recruited at three hospitals in the Southeast of
the Netherlands. Patients were not eligible in case of stage IV
disease and comorbidities obstructing successful participation
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(e.g., cognitive disorders such as Alzheimer disease). The
study has been registered at the Netherlands Trial Registry
(www.trialregister.nl, NL6904) and approved by the
Medical Ethics Committee of the University Hospital
Maastricht and Maastricht University (approval number
NL38786.068.11) in the Netherlands. Informed consent was
obtained from all participants. Exclusion criteria were ever
being diagnosed with stage IV CRC, having comorbidities
that would obstruct successful participations, being unable to
read or write Dutch, and having a home address outside the
Netherlands. For the present analyses, we used data collected
from April 2012 until July 2018. The post-treatment follow-
ups correspond to approximately 3, 6, 12, and 24months post-
diagnosis. In total, we used data of 445 participants who pro-
vided data on the alcohol variables at baseline (Fig. 1).
“Patient-reported outcomes ColoRectal cancer” study
The patient-reported outcomes ColoRectal cancer
(PROCORE) study, which started in 2016, is a prospective
population-based study, in which 478 newly diagnosed stage
I–IV adult CRC patients were recruited after diagnosis and the
follow-ups were after surgery and until 12 and 24 months
post-diagnosis via the PROFILES registry (Patient-Reported
Outcomes Following Initial treatment and Long term
Evaluation of Survivorship) [17]. Ethical approval for the
study was obtained from the certified Medical Ethics
Committee of Medical Research Ethics Committees United
(approval number NL51119.060.14). All respondents gave
informed consent. Patients were recruited from four Dutch
hospitals in the south of the Netherlands. Exclusion criteria
were ever being diagnosed with a different carcinoma, except
for basal cell carcinoma of the skin, and having cognitive
limitations or being unable to read or write Dutch, which did
not allow them to independently fill out a questionnaire. For
the current manuscript, we did not use the follow-up
after surgery, as we did not measure alcohol consump-
tion at that time point. The follow-ups were at 12 and
24 months post-diagnosis. Of all other time points, we
used data of 465 participants that entered their alcohol
consumption at baseline.
Alcohol consumption
In EnCoRe, pre-diagnosis alcohol consumption was assessed
retrospectively at diagnosis with a Food Frequency
Questionnaire (FFQ). During follow-up, 7-day food diaries
were used to assess alcohol consumption and intake of specif-
ic alcoholic beverages over the past week [18]. The validity of
the FFQ over the past year has been evaluated relative to 7-day
food diaries, and the intake of alcohol was highly correlated
between both methods (rho = 0.91) [19]. In PROCORE, alco-
hol consumption was recorded with a questionnaire about the
average frequency of alcohol consumption per day in the past
year, and the number of glasses of beer, wine, and liquor.
Alcohol consumption was defined as follows: (A) alcohol
consumption (y/n); (B) the number of drinks per week; (C)
consuming beer, wine, or liquor; (D) the number of beer,
wine, or liquor drinks per week; and (E) the categories of
non-drinkers, moderate drinkers (< 14 drinks per week), and
heavy drinkers (≥ 14 drinks/week), as provided in the Dutch
guidelines for good nutrition of the Health Council of the
Netherlands [20]. For each alcoholic drink, we assumed that
all types of alcoholic beverages, i.e., beer (5% alcohol in 250
mL), wine (12% alcohol in 100mL), or liquor (35% alcohol in
35 mL), contain 10 g ethanol per unit of consumption [20].
Sociodemographic and lifestyle factors
In both cohorts, information was collected about age, sex,
partner (yes/no), and working status (yes/no). Education
levels were recorded as having low education (lower vocation-
al and primary education), medium (intermediate vocational
and secondary education), and high level (higher vocational
and university). Participants’ level of moderate-to-vigorous
physical activity (MVPA, hours/week) was measured by the
Short QUestionnaire to ASsess Health-enhancing physical ac-
tivity (SQUASH) [21]. Information was available on self-
reported smoking (non-smoker, former, and current smoker),
and body height and weight to determine body mass index
(BMI, in kg/m2). Body height and weight were measured by
trained dieticians in the EnCoRe study, while they were self-
reported in the PROCORE study.
Fig. 1 Schematic representation of the two datasets and how they were pooled
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Clinical factors
Both studies collected information from medical records on
tumor localization (colon vs. rectum) and stage (I vs. II vs. III
or IV), and treatments received besides surgery (chemothera-
py and radiotherapy). Furthermore, the placement of a stoma
was self-reported. The Self-Administered Comorbidity
Questionnaire (SCQ) was used to assess the number of co-
morbidities (0, 1, ≥ 2) [22].
Statistical analyses
All variables were described as percentages or means and
standard deviations, or medians and interquartile ranges for
non-normally distributed factors.
To analyze how alcohol consumption changed over time,
we looked at the following: (A) alcohol consumption (y/n);
(B) the number of drinks per week; (C) consuming beer, wine,
or liquor; (D) the number of beer, wine, or liquor drinks per
week; and (D) the categories of non-drinkers, moderate, and
heavy drinkers for total alcohol, beer, wine, and liquor. We
compared the categories at each time point, and assessed how
survivors changed in alcohol consumption category from
baseline towards 12 months post-diagnosis.
In order to determine longitudinal associations of
sociodemographic, lifestyle, and clinical factors with alcohol
consumption over time, we used generalized estimating equa-
tions (GEE) with an exchangeable correlation structure, which
takes into account within-person correlations when examining
multiple observations per subject and can handle missing
values [23]. Alcohol consumption is considered as a non-
t rans formed outcome ( l ink = Ident i ty ) , and a l l
sociodemographic, lifestyle, and clinical factors as determi-
nants, while also correcting for cohort. We performed addi-
tional analyses in which we ran the same analyses with the
number of alcoholic drinks per week as the outcome including
only baseline and the time points 12 and 24 months post-
diagnosis, for which we had data from both cohorts.
All analyses were conducted using SPSS version 24.0
(IBM Corp., Armonk, NY, USA). Significance level
was set at p < 0.05, two-tailed.
Results
Sample characteristics
Study participants (n = 910) were on average 67 years old at
diagnosis, and 37% were female (Table 1). CRC patients in
PROCORE showed a slightly lower education level, more
often had a partner, more often adhered to physical activity
guidelines, had lower BMI, were more often diagnosed with
colon instead of rectum cancer, and were less often treated
with chemo- or radiotherapy compared to patients in
EnCoRe. Supplementary Tables 1A and 1B show the
characteristics of both the PROCORE and EnCoRe sam-
ples at each time point.
Changes over time in alcohol consumption
At baseline, 79% of the participants reported consuming alco-
hol (Table 2). At 3 and 6 months post-diagnosis, 68%was still
consuming, and the percentages of drinkers were 71% and
70% after 12 and 24 months, respectively. On average, survi-
vors drank 8.4 drinks per week at diagnosis, which decreased
to 7.8 drinks per week at 24 months post-diagnosis. At base-
line, 56% consumed moderate amounts and 23% were heavy
drinkers (Supplementary Table 2). Throughout the follow-up,
there seemed to be less moderate drinkers, and more non-
drinkers. Supplementary Table 3 shows the changes in cate-
gories from baseline towards 12 months post-diagnosis.
When we investigated beer, wine, and liquors, there were
51%, 58%, and 25% drinkers at baseline, respectively. During
follow-up, less survivors were consuming beer, wine, and
liquor, as compared to baseline, and there were 41%, 50%,
and 20% drinkers at the last follow-up (Table 2). The amount
of drinks of each beverage remained relatively constant over
time, with survivors reporting to drink roughly 4 beers per
week, 3–4 wines per week, and 1 glass of liquor per week.
Furthermore, the majority were non-drinkers or moderate
drinkers at all time points, and the number of heavy liquor
drinkers was very low (Supplementary Table 2).
Associations of sociodemographic, lifestyle, and
clinical factors with alcohol consumption
Table 3 shows longitudinal associations between
sociodemographic, lifestyle, and clinical factors with alcohol
use in multivariable analyses. Women reported consuming
less alcohol per week than men over time (Supplementary
Fig. 1). Additionally, a lower education level and the presence
of a stoma were associated with less alcohol consumption,
whereas more physical activity was related to more alcohol
consumption over time.
Survivors in the EnCoRe study reported more beer con-
sumption than survivors in the PROCORE study. Survivors
with lower age at baseline were consuming more beer, men
drank almost six glasses per week more than women, and
survivors with a stoma drank less beer. More wine consump-
tion was associated with higher education, more physical ac-
tivity, and former smoking. Survivors with tumor stage III or
IV drank more wine, whereas chemotherapy and presence of a
stoma were associated with less wine consumption. For use of
liquor, higher baseline age, being male, having a higher edu-
cation, being more physically active, having a higher BMI,
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and having received chemotherapeutic treatment were associ-
ated with higher consumption.
Additional analyses
We ran the analyses using only baseline, and the 12 and 24
months post-diagnosis time points. Survivors in the EnCoRe
study consumed more alcohol than survivors in the
PROCORE study. Although most associations were consis-
tent with the main analyses, now we saw that both former and
current smoking were associated with consuming two or three
glasses more per week, respectively, and a stoma placement
was not associated with alcohol consumption anymore
(Supplementary Table 4).
Discussion
In this pooled sample of two Dutch CRC survivor cohorts, we
observed that alcohol consumption is slightly decreasing after
Table 1 Baseline characteristics
of total sample, and the EnCoRe
vs. PROCORE datasets
Total (N = 910) EnCoRe (N = 445) PROCORE (N = 465)
Sociodemographics (N (%))
Age (years, mean (SD)) 66.9 (9.2) 66.7 (9.1) 67.0 (9.2)
Sex (females) 332 (36.5) 151 (33.9) 181 (38.9)
Education level
High 270 (29.7) 149 (33.5) 121 (26.4)
Medium 556 (61.5) 266 (59.8) 290 (63.2)
Low 78 (8.6) 30 (6.7) 48 (10.5)
Having a partner 752 (82.7) 356 (80.0) 396 (85.3)
Working 290 (32.6) 148 (33.3) 142 (31.9)
Lifestyle factors (median (IQR))
Physical activity (hours/week MVPA) a 11 (12) 11 (14) 11 (11)
Smoking categories
Never 273 (30.0) 139 (31.2) 134 (28.9)
Former 527 (58.0) 252 (56.6) 275 (59.3)
Current 109 (12.0) 54 (12.1) 55 (11.9)
BMI (kg/m2, mean (SD)) 27.4 (4.4) 28.3 (4.7) 26.6 (4.0)
Clinical factors (N (%)
Months since diagnosis (median (range)) 0.6 (0–11) 0.5 (0–5) 0.7 (0–11)
Tumor location
Colon 604 (66.4) 281 (63.1) 323 (69.5)
Rectum 303 (33.3) 164 (36.9) 139 (29.9)
Staging
I 254 (29.0) 122 (29.0) 132 (29.0)
II 236 (27.0) 102 (24.3) 134 (29.5)
III 367 (41.9) 196 (46.7) 171 (37.6)
IV 18 (2.1) - 18 (4.0)
Chemotherapy 325 (35.7) 178 (40.0) 147 (31.6)
Radiotherapy 194 (21.3) 112 (25.2) 82 (17.6)
Stoma placement 3 (0.3) 0 (0) 3 (0.7)
Number of comorbidities b
None 120 (26.2) - 120 (26.2)
1 157 (34.3) - 157 (34.3)
≥2 181 (39.5) - 181 (39.5)
aMVPA, moderate-to-vigorous physical activity
b Comorbidities are only measured from 3 months post-diagnosis follow-up in EnCoRe
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diagnosis, and remains lower up to 2 years post-diagnosis.
Over time, we found that survivors who were male, with
higher education, more physical activity, and survivors with-
out a stoma reported higher consumption of alcoholic drinks.
At baseline, we found that our study population had more
alcohol consumers than reported in other cancer survivor stud-
ies: 49% current consumers [14], 8%moderate consumers [24],
and 88% low alcohol consumption (≤ 1 drink/day) [25], but all
alcoholic consumptions seemed to decrease slightly in the 2
years post-diagnosis. This was in line with the paper of Bours
et al. stating that 95% drank less alcohol after CRC diagnosis in
a cross-sectional study 7 years post-diagnosis [26]. They saw
that alcohol use did not change from the first (roughly 5 years
after diagnosis) to the third survey of an ongoing longitudinal
study in CRC survivors, and concluded that these changes had
probably occurred closer to diagnosis [26]. Even though we see
this decrease in the general older population of the Netherlands
[27], their reasons for consuming less alcohol may be different
than for CRC survivors in whom the reasons may be related to
prevention of cancer recurrence, to improve health, and prevent
disease in general, as Bours et al. state [26].
Of the sociodemographic and lifestyle factors, we found that
male sex, a higher education level, and being more physically
active were related to higher alcohol consumption. We found
that men were consuming more alcohol than women at every
time point, in line with other studies [28]. Cortés-Ibáñez et al.
have found in 5473 Dutch cancer survivors (± 9 years post-
diagnosis) that after adjustments for age and sex, cancer survi-
vors drank less alcohol, more often had normal weight, and
were more physically active than the non-cancer participants,
pointing to an improved lifestyle after cancer diagnosis.
Another large cohort including 1153 Korean cancer survivors
(59% diagnosed within the past 5 years, and 19% > 10 years)
also found that (heavy) drinkers were younger, men, and had a
higher household income [14]. However, they did find that
drinkers were more often current smokers, and there was no
association with education or physical activity [14]. Possibly,
higher household incomewas a better marker for socioeconom-
ic status than education in the Korean cohort. Also, alcoholic
drinks were not related to smoking in our pooled cohort, only
former smoking was related to wine drinking. Moreover, when
we ran the analyses without the first follow-ups (3 and 6months
post-diagnosis), we did see that both former and current
smokers drank more alcohol. Lastly, the Korean study included
walking regularly as being physically active, and our definition
of physical activity adherence seems to bemore rigorous, and is
associated with consuming more. In general, it seems that can-
cer survivors tried to lead a better lifestyle, potentially driven by
their diagnosis and treatment as “teachable moments” that mo-
tivated them to make behavioral changes for improving their
health [29]. Breedveld-Peters et al. also reported that 64% of
155 CRC survivors were adhering to alcohol guidelines of the

















































































































































































































































































































































































































































































































































































































































































































































adherence [30]. Perhaps a better result may be achieved if more
people would be aware of the alcohol guidelines, as a study
from California showed that 15% of CRC survivors had never
heard of recommendations to limit alcohol [31].
Overall, alcohol consumption may be influenced by local cul-
ture. In the Netherlands, persons above 55 years reported to drink
in order to relax, to sleep better, or to have less pain or because they
believe it is good for health [27]. In interviews among the elderly,
75% of persons above 55 years did not know that alcohol is
addictive, and 83%did not knowabout its disadvantages for health
[27]. Persons reported that feeling lonely, having lost structure in
life (e.g., due to retirement) or have experienced large stress (e.g.,
CRC diagnosis in our sample), special occasions or social events
may be reasons for consuming alcohol [27].
In the specific analyses among beverage subtypes, we ob-
served an association between chemotherapy and consuming less
wine and more liquors. Survivors with stage III or IV CRC
reported more wine consumption over time. Also, we found an
association between patients with a stoma and less consumption
of alcohol, specifically less beer or wine. This may be due to
some of the problems these survivors encounter, such as a lower
quality of life, more concerns about their illness, and a higher
health care consumption compared with those without a stoma
1–10 years after diagnosis [32], sexual problems, or depressive
feelings [33]. According to the guidelines in the Netherlands for
patients with a colostomy, they should be careful with drinking
carbonated drinks (e.g., beer) due to its effect on flatulence [34].
Furthermore, some papers found that heavy drinking was asso-
ciatedwith a risk of anastomotic leaks [35] or parastomal bulging
[36].
The results of our study should be interpreted while taking
into account the following limitations. Firstly, it is important to
recognize that each study uses different cut-offs for moderate and
heavy drinking. Some studies defined moderate alcohol con-
sumption as 5–15 g per day for females and 5–30 g per day for
males [24], and others state that heavy consumption is ≥ 60 g
alcohol (seven drinks) for males and ≥40 g (five drinks) for
females, twice or more per week [14]. We currently use the
guidelines for good nutrition of the Health Council of the
Netherlands, stating that 14 drinks per week are defined as mod-
erate alcohol consumption [20]. Furthermore, alcohol consump-
tion was measured both with the FFQ over the past year and 7-
day food diaries, which may limit the harmonization of the two
datasets. Nevertheless, the intake of alcohol was highly correlat-
ed between both methods (rho = 0.91) [19]. Next, we pooled and
harmonized two studies that had slightly different time points at
Table 3 Longitudinal multivariable associations of sociodemographic, lifestyle, and clinical factors with total alcoholic drinks and types of drinks per
week
Alcohol drinks/week Beer drinks/week Wine drinks/week Liquor drinks/week
B (SE) p B (SE) p B (SE) p B (SE) p
Cohort (ref = PROCORE) 1.13 (0.81) .16 1.62 (0.67) .02 0.13 (0.40) .74 − 0.24 (0.19) .20
Sociodemographics
Baseline age − 0.04 (0.05) .36 − 0.11 (0.04) .003 0.03 (0.02) .14 0.03 (0.01) .02
Sex (ref = male) − 6.18 (0.72) < .001 − 5.64 (0.50) <.001 0.33 (0.39) .40 − 0.46 (0.18) .01
Education levels (ref = high)
Medium − 2.85 (1.17) .003 0.99 (0.70) .16 − 3.36 (0.49) < .001 − 0.50 (0.28) .07
Low − 5.36 (0.94) < .001 0.53 (0.88) .55 − 4.88 (0.58) < .001 − 0.84 (0.39) .03
Having a partner (ref = no) − 1.32 (0.91) .15 − 0.31 (0.61) .61 − 0.15 (0.35) .67 0.03 (0.32) .93
Working (ref = no work) 0.90 (0.92) .33 0.38 (0.91) .68 0.25 (0.38) .51 − 0.24 (0.19) .21
Lifestyle
Physical activity (hours) 0.05 (0.02) .03 0.02 (0.02) .26 0.03 (0.01) .01 0.02 (0.01) .02
Body mass index (kg/m2) 0.30 (0.18) .08 0.06 (0.14) .64 0.03 (0.06) .65 0.07 (0.02) .002
Smoking categories (ref = never)
Former smoker − 0.05 (0.77) .95 − 0.03 (0.34) .94 0.95 (0.43) .03 − 0.01 (0.18) .95
Current smoker − 2.23 (2.24) .32 − 1.11 (0.86) .20 0.98 (0.72) .17 0.29 (0.39) .46
Clinical factors
Months since diagnosis a − 0.04 (0.02) .03 − 0.01 (0.01) .56 − 0.02 (0.01) .04 − 0.01 (0.00) .002
Tumor location (ref = colon cancer) 1.22 (1.13) .28 0.59 (0.97) .55 0.46 (0.61) .45 0.09 (0.26) .74
Tumor staging (ref = stage I)
Stage II 0.19 (1.04) .86 0.20 (0.88) .82 − 0.11 (0.49) .82 0.07 (0.26) .78
Stage III or IV − 0.96 (1.09) .38 − 1.35 (0.80) .09 1.17 (0.60) .05 − 0.47 (0.36) .19
Chemotherapy (ref = no) 0.76 (1.11) .49 0.85 (0.81) .30 − 1.18 (0.56) .04 0.80 (0.38) .03
Radiotherapy (ref = no) − 0.02 (1.40) .99 − 0.40 (1.07) .71 − 0.05 (0.76) .95 0.07 (0.40) .87
Stoma placement (ref = no) − 2.21 (0.75) .003 − 1.33 (0.66) .05 − 0.84 (0.31) .01 0.09 (0.21) .67
Number of comorbidities (ref = none)
1 − 0.26 (0.59) .67 0.06 (0.43) .90 − 0.61 (0.35) .08 0.07 (0.17) .70
≥ 2 − 0.04 (0.73) .96 − 0.11 (0.53) .84 − 0.62 (0.38) .11 0.06 (0.19) .76
P-values < 0.05 are represented bold
aMonths since diagnosis was entered into the models as a measure of time
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follow-up after diagnosis. Therefore, all analyses were corrected
for months since diagnosis. In addition, we performed additional
analyses, merely analyzing the similar time points (baseline, 12
months, and 24 months), and these results were largely consis-
tent. Another limitation was that all lifestyle factors were self-
reported, and hence, we cannot exclude the possibility that par-
ticipants answered questions in a socially desirable manner.
An important strength of the present study is that pooled
analyses were performed using two longitudinal databases with
repeated measurements of survivors prospectively followed up
for a period of approximately 2 years from the moment of CRC
diagnosis. Most other studies included patients longer after diag-
nosis or performed cross-sectional analyses.
Conclusions
To our knowledge, this is the first study in CRC survivors that
longitudinally analyzed consumption of alcohol and specific al-
coholic beverages in relation to sociodemographic, lifestyle, and
clinical factors. From CRC diagnosis until 2 years post-diagno-
sis, we found that most survivors are modestly decreasing their
alcohol consumption. Several sociodemographic, lifestyle, and
clinical factors were related to alcohol consumption over time,
including sex, education level, physical activity, and having a
stoma. The findings give insight into characteristics of CRC
survivors that use alcohol, which should be taken into account
in future analyses of alcohol on cancer outcomes.
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